Clinical trials represent a crucial stage in medical research which allow better ways to prevent, explore, diagnose, or treat diseases to be found, as well as allowing new therapies to be formalized.
They are only performed when there is reason to believe that the treatment being tested, having been previously studied in the laboratory, can be beneficial to patients.
INCLIVA, following the rigorous efficacy and safety protocols of its Clinical Research Ethics Committee (CEIC; Comité Ético de Investigación Clínica), manages clinical studies—clinical trials, observational studies, and research projects— from the University Clinical Hospital (Hospital Clínico Universitario) and the Malvarrosa-Clinic (Clínic-La Malva-Rosa) Health Department, both in Valencia. Because Incliva is a Health Research Institute (IIS; Instituto de Investigación Sanitaria), it can complete all the required stages for developing new drugs and medical devices.
In particular, the clinical trials developed by the Hospital’s Oncology and Hematology Services, stand out for their internationally recognized advances. In recent years, the number of these types of clinical trials has increased, and in 2015, exceeded 200.
One of the attributes of the IIS INCLIVA that differentiates it is its Phase I Clinical Trials Unit, responsible for carrying out the first stage of human drugs testing, one of the few units that exist in Spain.
In 2015 the INCLIVA Foundation had more than 355 active clinical trials and had already established itself as an international leader in oncological clinical trials.